Lv32
322 积分 2023-07-26 加入
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
14天前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
21天前
已完结
[Consensus on immunotherapy for small cell lung cancer(2024 edition)]
21天前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
21天前
已完结
Lupus Nephritis: Unmet Needs and Evolving Solutions
27天前
已完结
Lupus Nephritis
27天前
已完结
Improving outcomes and mitigating costs associated with CAR T-cell therapy
28天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
28天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Bioinformatically Informed Design of Synthetic Mammalian Promoters
1个月前
已完结
皖公网安备34019202002308
